News Release
Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific Instruction to Continental Stock Transfer & Trust Company Regarding the Dividend of Scilex Holding Company Common Stock
The dividend confirmation statements are being distributed on behalf of Sorrento and
According to Sorrento’s estimates, approximately 60 million or more shares of Sorrento common stock were sold “short” as of the Record Date. In the event the shares of Sorrento common stock were held through a brokerage firm, bank, dealer or other similar organization and were sold “short” as of the Record Date, holders should consult with their financial advisor, broker or other agent immediately to determine whether they may also be deemed “short”
Each Record Common Holder is entitled to receive 0.1410127 of a share of
In the event that brokerage firms did not receive copies of the Dividend Confirmation Statements, please contact CST immediately. Sorrento and
Sorrento and
- When beneficial holders call CST:
- CST will direct the beneficial holders to contact their brokers.
- When brokers call CST:
- CST needs to confirm with the broker that such broker has received their Dividend Confirmation Statement.
- If brokers did not get the Dividend Confirmation Statement, CST will distribute the Dividend Confirmation Statement again to the applicable broker.
- CST will communicate to the brokers that Sorrento and
Scilex demand that brokers distribute theScilex common stock to the individual accounts of the beneficial holders. - If brokers refuse to distribute the
Scilex common stock, Sorrento andScilex will work with CST and the beneficial holder in exiting their brokerage accounts out of “street” name and into book entry format with CST so that the beneficial holder becomes the direct holder of record with CST. The beneficial holders will be charged$15 for the exit of such positions from their brokerage accounts.
To obtain a copy of the Dividend Confirmation Statement and to have the Dividend Stock reflected on such Dividend Confirmation Statement further distributed to the actual beneficial owners thereof, please contact Scilex’s transfer agent, CST, by phone or email at:
Telephone Number: 800-509-5586
Email Address: cstmail@continentalstock.com
Broker List
Broker |
Broker Address | Broker |
Broker Address | |
https://www.abnamro.com/clearing/en/contact-form |
175 IL |
information@albertfried.com |
45 24TH FLOOR 10006 US |
|
https://www.amalgamatedbank.com/contact |
275 7TH AVENUE NY |
contactus@americanenterprise.com |
682 AMERIPRISE FINANCIAL CENTER MN |
Broker |
Broker Address | Broker |
Broker Address | |
cs@apexclearing.com |
2 CENTER NJ |
1.800.878.7878 https://www.privatebank.bankofamerica.com/find-an-advisor.html |
901 MAIN STREET 12TH FLOOR TX |
|
BANK OF NEW YORK MELLON gceamericas@bnymellon.com |
111 SANDERS CREEK PARKWAY 2ND FLOOR 2ND FLOOR |
corporateactionsu@barclays.com |
DTC CUSTODY PARTICIPANT- NY WINDOW -570 07310 US |
|
corporateactionsu@barclays.com |
DTC CUSTODY PARTICIPANT- NY WINDOW -570 NJ |
https://capitalmarkets.bmo.com/en/contact-us/ |
3 2ND STREET 12TH FLOOR |
|
https://www.bmoharris.com/main/contact-us/ |
11270 W PARK PL WI |
NACom.Compliance@bmo.com |
250 7TH FLOOR 7TH FLOOR TORONTO ON |
|
BROKERAGE CUSTODIAN alex.bergelson@us.bnpparibas.com |
100 WEST 33RD STREET 3RD FLOOR 10001 |
BROKERAGE CUSTODIAN alex.bergelson@us.bnpparibas.com |
100 WEST 33RD STREET 3RD FLOOR 10001 |
|
BNY MELLON gceamericas@bnymellon.com |
PO BOX 392002 500 PA |
BNY MELLON/WEALTH MANAGEMENT gceamericas@bnymellon.com |
1 FREEDOM VALLEY DRIVE OAKS PA |
|
BNYMELLON gceamericas@bnymellon.com |
111 SANDERS CREEK PARKWAY 2ND FLOOR 2ND FLOOR |
BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD. gceamericas@bnymellon.com |
ONE WALL STREET NY |
Broker |
Broker Address | Broker |
Broker Address | |
NY |
||||
BNYMELLON/RE CACEIS BANK LUXEMBOURG gceamericas@bnymellon.com |
BNY Mellon Center PITTSBURGH PA 15258 |
BNYMELLON/RE CACEIS BANK, gceamericas@bnymellon.com |
111 SANDERS CREEK PARKWAY |
|
BNYMELLON/RE gceamericas@bnymellon.com |
111 SANDERS CREEK PARKWAY 2ND FLOOR 2ND FLOOR 13057 US |
BNYMELLON/RE ETF - ISHARES DTC/ gceamericas@bnymellon.com |
111 SANDERS CREEK PARKWAY |
|
BNYMELLON/RE WINTERFLOOD SECURITIES LTD gceamericas@bnymellon.com |
BNY Mellon Center PITTSBURGH PA |
corey.j.colvin@bankofamerica.com |
FL9-803-04-04- 4th floor 32246 US |
|
corey.j.colvin@bankofamerica.com |
FL9-803-04-04- 4th floor 32246 US |
SECURITIES INC corey.j.colvin@bankofamerica.com |
FL9-803-04-04- 4th floor 32246 US |
|
contactus@bbh.com |
140 BROADWAY ATTN: CORPORATE ACTIONS VAULT NY |
contactus@bbh.com |
140 BROADWAY NY |
|
reception@caldwellsecurities.com |
55 UNIVERSITY AVENUE SUITE 340 TORONTO ON M5J 2H7 |
investor.relations@cgf.com |
609 GRANVILLE ST BC V7Y 1H2 CA |
|
https://www.cantor.com/investor-center/ |
135 E 57TH ST 5TH FL NY |
cdscustomersupport@tmx.com |
100 ON M5H 1S3 CA |
|
reorg@ceterafi.com |
400 FIRST STREET SOUTH, SUITE 300 SUITE 300 ST. CLOUD |
CHARLES SCHWAB & CO., INC. 800-435-4000 https://www.schwab.com/contact-us |
211 MAIN STREET 94105 US |
Broker |
Broker Address | Broker |
Broker Address | |
MN |
||||
CI INVESTMENT SERVICES INC. info.ciis@ci.com |
199 SUITE 2600 TORONTO ON |
info@cibc.com. |
161 TORONTO ON M5J 2S8 CA |
|
1-800-950-5114 |
3800 CITIGROUP CENTER B2/2 FL |
1-800-950-5114 |
3800 CITIBANK CENTER FL |
|
1-800-950-5114 |
580 CROSSPOINT PARKWAY NY |
https://clearstreet.io/contact |
4 150 Greenwich Street NY |
|
CLEARSTREET IO info@clearstreet.io |
55 (SUITE 2102) CORPORATE ACTIONS |
brokerage.newaccounts@commercebank.com |
922 WALNUT STREET MAIL STOP TBTS-2 |
|
dividend.interests@axosclearing.com |
9300 UNDERWOOD AVE SUITE 400 OMAHA |
clientcare@credential.com |
800-1111 WEST GEORGIA STREET BC V6E 4T6 CA |
|
CREST INTERNATIONAL NOMINEES LIMITED Admin@crest-approved.org |
33 |
info@curvaturesecurities.com |
39 MAIN STREET NJ |
|
https://dadavidson.com/Contact-Us |
8 3RD STREET 59401 US |
DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORES https://www.dcv.cl/en/contact.html |
AVENIDA APOQUINDO # 4001 FLOOR 12, C.P. 7550162, |
Broker |
Broker Address | Broker |
Broker Address | |
DESJARDINS SECURITIES INC. asfaires@desjardins.com |
1253 H3B 2Y5 CA |
deutsche.bank@db.com |
1251 Avenue Of The Americas |
|
intm.corporate-actions@db.com |
60 WALL STREET 9TH FLOOR |
https://www.drivewealth.com/lets-build-together/ |
15 EXCHANGE PLACE 10TH FLOOR |
|
E* https://us.etrade.com/contact-us |
HARBORSIDE FINANCIAL CENTER 501 PLAZA 11 JERSEY CITY NJ |
1 (800) 441-2357 |
12555 MANCHESTER ROAD |
|
1 (800) 441-2357 |
201 PROGRESS PARKWAY |
FIDELITY CLEARING ULC/CDS** acctransfer.fcc@fidelity.ca |
483 BAY ST. SOUTH TOWER TORONTO ON |
|
1-866-671-5353 |
5001 MAIL DROP 1MOB28 |
https://folioinvesting.com/folioinvesting/contact-us/ |
8180 8TH FLOOR VA |
|
FUTU CLEARING INC. customersvc@futuclearing.com |
SUITE 475 DALLAS TX |
416 943 6696 |
145 WEST, SUITE 300 11TH FLOOR TORONTO ON MJ5 1J8 CA |
|
gs-investor-relations@gs.com. |
222 SOUTH MAIN STREET Attn: Mandatory Corporate Actions 84101 US |
https://www.haywood.com/who-we-are/locations |
200 BURRARD ST WATERFRONT BC V6C 3L6 |
|
https://www.hilltopsecurities.com/contact/ |
1201 ELM ST. 35TH FLOOR TX 75270 US |
voicemail@hudson-trading.com |
150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER |
Broker |
Broker Address | Broker |
Broker Address | |
57TH FLOOR 10007 US |
||||
STOCK LOAN https://www.us.hsbc.com/customer-service/contact-us/ |
452 FIFTH AVENUE ATTN: HBUS CCS SETTS 10018 US |
investorrelations@hsbc.com |
452 FIFTH AVENUE ATTN: HBUS CCS SETTS 10018 US |
|
877-442-2757 |
2 PICKWICK PLAZA 2ND FLOOR CT 06830 US |
https://am.jpmorgan.com/us/en/asset-management/adv/contact-us/ |
1111 43240 |
|
(347) 643-1000 |
FOUR CHASE METROTECH CENTER 3RD FLOOR 11201 US |
taxreportingwccontacts@janney.com |
1717 17TH FLOOR PA |
|
https://www.jefferies.com/FooterPages/Contact-Us/94 |
101 HUDSON STREET, 11th Floor NJ |
JPMCinvestorrelations@jpmchase.com |
FOUR CHASE METROTECH CENTER 3RD FLOOR 11201 US |
|
JPMCinvestorrelations@jpmchase.com |
FOUR CHASE METROTECH CENTER 3RD FLOOR 11245 US |
JPMCinvestorrelations@jpmchase.com |
FOUR CHASE METROTECH CENTER 3RD FLOOR 11201 US |
|
https://www.key.com/personal/customer-support/contact-us.html |
4900 TIEDEMAN RD |
LAURENTIAN BANK SECURITIES INC. https://www.vmbl.ca/portal/web/site_public/contactez-nous |
1981 MCGILL COLLEGE AVE. SUITE 100 MONTREAL QUEBEC H3A 3K3 CA |
|
renata.jaskiewicz@lpl.com |
4707 EXECUTIVE DRIVE CA |
https://www3.mtb.com/homepage/explore-the-m-and-t-bank-help-center/mandt-bank-phone-numbers-by-department/telephone-directory |
ONE M&T PLAZA TRUST OPS 8TH FLOOR NY |
Broker |
Broker Address | Broker |
Broker Address | |
MLS_securitiesoperations@manulife.ca |
1235 NORTH SERVICE ROAD ON L6M 2W2 CA |
MARSCO INVESTMENT CORPORATION op@tradeup.com |
101 EISENHOWER PARKWAY NJ |
|
https://www.ml.com/contactus/contact-us.html |
FL9-803-04-04- 4th floor 32246 US |
MIRAE ASSET SECURITIES ( 212-407-1000 |
810 SEVENTH AVE 37TH FLOOR NY |
|
MIRAE ASSET SECURITIES ( 212-407-1000 |
810 SEVENTH AVE 37TH FLOOR |
BRANCH https://safe.tr.mufg.jp/cgi-bin/english/index_contact/index_contact_01.cgi?r=7 |
280 PARK AVE 39TH FL-WEST BLDG NY |
|
Morgan Stanley info@morganstanley.com |
1300 THAMES STREET WHARF MD |
info@morganstanley.com |
1300 MD |
|
MORGAN STANLEY SMITH BARNEY LLC investorrelations@morganstanley.com |
1 39TH FLOOR NY |
service@siebert.com |
77 3RD FLOOR |
|
http://www.national-financial-services.com/contact_us/ |
499 WASHINGTON BOULEVARD 5TH FLOOR 07310 US |
NBINinformation@nbc.ca |
1010 rue De La Gauchetière Mezzanine 100 MONTREAL QUEBEC H3B 5J2 CA |
|
https://www.nomuraholdings.com/news/contact/ |
309 WEST 49TH STREET 10TH FLOOR 10019 US |
information@odlumbrown.com |
250 SUITE 1100 VANCOUVER BC V6C 3R8 CA |
|
michael.shih@opco.com |
85 BROAD STREET NY |
https://www.pershing.com/contact/ |
1 PERSHING PLAZA NJ |
Broker |
Broker Address | Broker |
Broker Address | |
PHILLIP CAPITAL INC. corporateactions@phillipcapital.com |
141 BLVD. SUITE 3050 CHICAGO IL |
reorg@pifinancial.com |
666 SUITE 1900 V6C 3N1 CA |
|
consumerloans@pnc.com |
4100 W 150TH STREET ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7- YB17-03-03 |
https://www.principal.com/contact-us |
711 HIGH STREET IA |
|
compliance@questrade.com |
5650 YONGE ST., Suite 1700 TORONTO ON |
ClientAccessSupport@RaymondJames.com |
880 CARILLON PKWY FL |
|
corporateactions@raymondjames.com |
925 WEST BC |
rbcrundle@rbccm.com |
60 SOUTH 6TH ST. |
|
dsonline@rbc.com |
21 COMMERCE COURT SOUTH 2ND FLOOR TORONTO ON M5L 1A7 |
https://www.reliancetrustgroup.com/contact |
1100 500 NORTHPARK SUITE 400 ATLANTA 30113 US |
|
janed@reliance-trust.com |
4900 W. BROWN DEER RD |
dividends@rwbaird.com |
777 9TH FLOOR 53202 US |
|
ir@robinhood.com |
500 COLONIAL CENTER PARKWAY SUITE 100 LAKE MARY FL 32746 US |
https://www.safrasecurities.com/Contact.aspx |
546 5TH AVENUE NY |
Broker |
Broker Address | Broker |
Broker Address | |
investor.relations@scotiabank.com |
150 5TH FLOOR TORONTO ON |
https://www.seic.com/contact-us |
1 FREEDOM VALLEY DRIVE OAKS PA |
|
https://www.seic.com/contact-us |
1 FREEDOM VALLEY DRIVE OAKS PA 19456 US |
https://americas.societegenerale.com/en/contact/ |
480 20TH FLOOR 07310 US |
|
SSB - BLACKROCK INSTITUTIONAL TRUST groupcorpcommsamrs@blackrock.com |
50 California Street San Francisco CA |
SSB - TRUST CUSTODY ssb@dss.ca.gov |
30 SUITE 800 TORONTO ON |
|
SSB&T CO/CLIENT CUSTODY SERVICES https://www.ssbtexas.com/contact |
1776 HERITAGE DRIVE |
ses-client-service@statestreet.com |
16 WALL STREET 5TH FLOOR NY |
|
ses-client-service@statestreet.com |
1776 HERITAGE DRIVE 02171 |
ses-client-service@statestreet.com |
1776 Heritage Drive |
|
ses-client-service@statestreet.com |
30 SUITE 800 TORONTO ON M5C 3G6 CA |
investorrelations@stifel.com |
501 N BROADWAY MO MISSOURI 63102 US |
|
STONEX FINANCIAL INC. dg-clre-org_tenders@stonex.com |
2 PERIMETER PARK SOUTH SUITE 100 35243 US |
https://www.tdameritrade.com/why-td-ameritrade/contact-us.html |
200 S 108TH AVE |
|
TD WATERHOUSE https://www.tdameritrade.com/why-td-ameritrade/contact-us.html |
77 3RD FLOOR TORONTO ON M5S 1M2 CA |
mathewwilliams@ttstc.org |
208 E 10TH TX |
Broker |
Broker Address | Broker |
Broker Address | |
THE BANK OF NEW YORK MELLON gceamericas@bnymellon.com |
500 27TH FLOOR |
https://www.huntington.com/customer-service/contact-us |
7 |
|
https://www.northerntrust.com/united-states/contact-us-corporate-overview |
IL |
corpactions@tradestation.com |
120 SUITE 1650 CHICAGO IL |
|
corporateactions@usbank.com |
60 EP-MN-WN1B MN |
https://www.usbank.com/investment-services/contact-us.html |
1555 N RIVER CENTER DRIVE |
|
https://www.usbank.com/investment-services/contact-us.html |
1555 NORTH RIVERCENTER DRIVE, SUITE 302 SUITE 302 MILWAUKEE WI |
UBS AG https://www.ubs.com/global/en/our-firm/locations.html |
480 12TH FLOOR |
|
comments@ubs.com |
1000 HARBOR BOULEVARD 07086 US |
https://www.ubs.com/us/en/wealth-management/contact-us.html |
677 CT |
Broker |
Broker Address | Broker |
Broker Address | |
shareholder@computershare.com |
928 GRAND BLVD |
VANGUARD MARKETING CORPORATION https://corporate.vanguard.com/content/corporatesite/us/en/corp/contact-us.html |
100 VANGUARD BLVD PA |
|
Christopher.Felicetti@velocityclearingllc.com |
Suite 109 (Attn: |
dl-operations@velox-global.com |
2400 E. KATELLA AVENUE SUITE 725A CA |
|
investor_relations@virtu.com |
ONE 10006 US |
VISION FINANCIAL MARKETS LLC securitiesops@vfmarkets.com |
4 HIGH CT |
|
reorg@wedbush.com |
1000 8TH FLOOR CA 90017 US |
reorg@wedbush.com |
1000 |
|
https://www.wellsfargo.com/help/contact-us/ |
733 MN |
https://www.wellsfargo.com/help/contact-us/ |
1 NORTH JEFFERSON MAIL CODE: H0006- 094 |
|
https://www.wellsfargo.com/help/contact-us/ |
1525 WEST W T HARRIS BLVD 28262 US |
WILSON- dfurlow@wdco.com |
236 SOUTH MAIN STREET 84101 US |
About Sorrento Therapeutics, Inc.
Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors (“TKIs”), fully human antibodies (“G-MAB™ library”), immuno-cellular therapies (“DAR-T™”), antibody-drug conjugates (“ADCs”), and oncolytic virus (“Seprehvec™”). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™.
Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin (“RTX”), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in
For more information visit www.sorrentotherapeutics.com
Media and Investor Relations
Contact:
Email: mediarelations@sorrentotherapeutics.com
Sorrento® and the Sorrento logo are registered trademarks of
G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of
SEMDEXA™ (SP-102) is a trademark of
ZTlido® is a registered trademark owned by
©2023

Source: Sorrento Therapeutics, Inc.